Ronald A. Lubet

15.2k total citations · 1 hit paper
344 papers, 12.7k citations indexed

About

Ronald A. Lubet is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Ronald A. Lubet has authored 344 papers receiving a total of 12.7k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Molecular Biology, 98 papers in Oncology and 91 papers in Genetics. Recurrent topics in Ronald A. Lubet's work include Estrogen and related hormone effects (62 papers), Inflammatory mediators and NSAID effects (57 papers) and Pharmacogenetics and Drug Metabolism (49 papers). Ronald A. Lubet is often cited by papers focused on Estrogen and related hormone effects (62 papers), Inflammatory mediators and NSAID effects (57 papers) and Pharmacogenetics and Drug Metabolism (49 papers). Ronald A. Lubet collaborates with scholars based in United States, Italy and Japan. Ronald A. Lubet's co-authors include Vernon E. Steele, Gary J. Kelloff, Raymond W. Nims, Ming You, Yian Wang, Clinton J. Grubbs, Karen Seibert, James A. Crowell, Ernest T. Hawk and Caroline C. Sigman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nano Letters and Gastroenterology.

In The Last Decade

Ronald A. Lubet

341 papers receiving 12.3k citations

Hit Papers

Dealkylation of pentoxyresorufin: A rapid and sensitive a... 1985 2026 1998 2012 1985 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald A. Lubet United States 57 5.4k 3.0k 2.7k 2.3k 2.2k 344 12.7k
Vernon E. Steele United States 57 5.7k 1.0× 2.1k 0.7× 2.8k 1.0× 2.1k 0.9× 1.9k 0.9× 293 11.9k
Takuji Tanaka Japan 65 6.6k 1.2× 2.4k 0.8× 2.4k 0.9× 1.7k 0.8× 1.2k 0.5× 409 14.7k
Bandaru S. Reddy United States 76 6.0k 1.1× 3.3k 1.1× 3.4k 1.3× 3.3k 1.4× 2.3k 1.1× 194 15.9k
Chinthalapally V. Rao United States 62 6.4k 1.2× 4.8k 1.6× 4.2k 1.6× 3.8k 1.7× 2.1k 0.9× 262 16.9k
Shantu Amin United States 60 9.0k 1.7× 2.3k 0.8× 3.0k 1.1× 864 0.4× 808 0.4× 437 15.4k
Thomas E. Eling United States 67 5.7k 1.1× 1.2k 0.4× 1.7k 0.6× 3.5k 1.6× 1.4k 0.6× 294 15.0k
Sanjay Gupta United States 69 7.2k 1.3× 1.9k 0.6× 2.6k 1.0× 2.7k 1.2× 993 0.4× 286 15.1k
William P. Steward United Kingdom 67 7.4k 1.4× 4.3k 1.4× 2.0k 0.7× 1.8k 0.8× 635 0.3× 221 18.3k
Ann M. Bode United States 77 12.4k 2.3× 4.1k 1.4× 3.3k 1.2× 1.4k 0.6× 811 0.4× 422 21.1k
Jing‐Gung Chung Taiwan 69 10.4k 1.9× 2.0k 0.7× 2.7k 1.0× 3.2k 1.4× 509 0.2× 550 18.8k

Countries citing papers authored by Ronald A. Lubet

Since Specialization
Citations

This map shows the geographic impact of Ronald A. Lubet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald A. Lubet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald A. Lubet more than expected).

Fields of papers citing papers by Ronald A. Lubet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald A. Lubet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald A. Lubet. The network helps show where Ronald A. Lubet may publish in the future.

Co-authorship network of co-authors of Ronald A. Lubet

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald A. Lubet. A scholar is included among the top collaborators of Ronald A. Lubet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald A. Lubet. Ronald A. Lubet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dragnev, Konstantin H., Ronald A. Lubet, Mark Steven Miller, et al.. (2023). Primary Prevention and Interception Studies in RAS-Mutated Tumor Models Employing Small Molecules or Vaccines. Cancer Prevention Research. 16(10). 549–560. 3 indexed citations
2.
Madka, Venkateshwar, Gaurav Kumar, Gopal Pathuri, et al.. (2021). Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat. Cancer Prevention Research. 14(11). 1009–1020. 6 indexed citations
3.
Mohammed, Altaf, Mark Steven Miller, Ronald A. Lubet, et al.. (2019). Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers. Cancer Prevention Research. 13(3). 273–282. 8 indexed citations
4.
Lubet, Ronald A., Vernon E. Steele, Robert H. Shoemaker, & Clinton J. Grubbs. (2018). Screening of Chemopreventive Agents in Animal Models: Results on Reproducibility, Agents of a Given Class, and Agents Tested During Tumor Progression. Cancer Prevention Research. 11(10). 595–606. 4 indexed citations
5.
Lubet, Ronald A., James M. Scheiman, Ann M. Bode, et al.. (2015). Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy. Cancer Prevention Research. 8(4). 296–302. 13 indexed citations
6.
Zhang, Qi, Jing Pan, Ronald A. Lubet, et al.. (2015). Enhanced Antitumor Activity of 3-Bromopyruvate in Combination with Rapamycin In Vivo and In Vitro. Cancer Prevention Research. 8(4). 318–326. 21 indexed citations
7.
Nicastro, Holly L., Clinton J. Grubbs, M. Margaret Juliana, et al.. (2013). Preventive Effects of NSAIDs, NO-NSAIDs, and NSAIDs Plus Difluoromethylornithine in a Chemically Induced Urinary Bladder Cancer Model. Cancer Prevention Research. 7(2). 246–254. 20 indexed citations
8.
Kim, Mi-Sung, Jong‐Eun Kim, Do Young Lim, et al.. (2013). Naproxen Induces Cell-Cycle Arrest and Apoptosis in Human Urinary Bladder Cancer Cell Lines and Chemically Induced Cancers by Targeting PI3K. Cancer Prevention Research. 7(2). 236–245. 69 indexed citations
9.
Mikulec, Carol, Joyce E. Rundhaug, Melissa Simper, Ronald A. Lubet, & Susan M. Fischer. (2013). The Chemopreventive Efficacies of Nonsteroidal Anti-inflammatory Drugs: The Relationship of Short-term Biomarkers to Long-term Skin Tumor Outcome. Cancer Prevention Research. 6(7). 675–685. 24 indexed citations
10.
Lü, Yan, Ming You, Zara Ghazoui, et al.. (2013). Concordant Effects of Aromatase Inhibitors on Gene Expression in ER+ Rat and Human Mammary Cancers and Modulation of the Proteins Coded by These Genes. Cancer Prevention Research. 6(11). 1151–1161. 10 indexed citations
11.
Disis, Mary L., Ekram Gad, Daniel R. Herendeen, et al.. (2013). A Multiantigen Vaccine Targeting Neu, IGFBP-2, and IGF-IR Prevents Tumor Progression in Mice with Preinvasive Breast Disease. Cancer Prevention Research. 6(12). 1273–1282. 59 indexed citations
12.
Oi, Naomi, Hanyong Chen, Myoung Ok Kim, et al.. (2012). Taxifolin Suppresses UV-Induced Skin Carcinogenesis by Targeting EGFR and PI3K. Cancer Prevention Research. 5(9). 1103–1114. 72 indexed citations
13.
Xie, Hua, Mee‐Hyun Lee, Feng Zhu, et al.. (2012). Identification of an Aurora Kinase Inhibitor Specific for the Aurora B Isoform. Cancer Research. 73(2). 716–724. 26 indexed citations
14.
Zhang, Qi, Jing Pan, Paula E. North, et al.. (2012). Aerosolized 3-Bromopyruvate Inhibits Lung Tumorigenesis without Causing Liver Toxicity. Cancer Prevention Research. 5(5). 717–725. 35 indexed citations
15.
Kim, Dong Joon, Kanamata Reddy, Myoung Ok Kim, et al.. (2011). (3-Chloroacetyl)-indole, a Novel Allosteric AKT Inhibitor, Suppresses Colon Cancer Growth In Vitro and In Vivo. Cancer Prevention Research. 4(11). 1842–1851. 27 indexed citations
16.
Wang, Yian, Zhongqiu Zhang, Joel R. Garbow, et al.. (2009). Chemoprevention of Lung Squamous Cell Carcinoma in Mice by a Mixture of Chinese Herbs. Cancer Prevention Research. 2(7). 634–640. 34 indexed citations
17.
Mei, Fan, Qi Zhang, Yukihiko Hara, et al.. (2009). Lung Cancer Inhibitory Effect of Epigallocatechin-3-Gallate Is Dependent on Its Presence in a Complex Mixture (Polyphenon E). Cancer Prevention Research. 2(6). 531–537. 43 indexed citations
18.
Yan, Yan, Yan Lü, Min Wang, et al.. (2006). Effect of an Epidermal Growth Factor Receptor Inhibitor in Mouse Models of Lung Cancer. Molecular Cancer Research. 4(12). 971–981. 27 indexed citations
19.
Lü, Yan, Ruisheng Yao, Yan Yan, et al.. (2006). A Gene Expression Signature that Can Predict Green Tea Exposure and Chemopreventive Efficacy of Lung Cancer in Mice. Cancer Research. 66(4). 1956–1963. 29 indexed citations
20.
Bosland, Maarten C., William D. Johnson, Michael Cwik, et al.. (2004). Lack of chemopreventive activity of lycopene in the Wistar-Unilever rat prostate cancer model. Cancer Research. 64. 900–900. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026